| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |